Among them, the expression levels of CDKN2A, GLS and LIPT1 were significantly upregulated whereas the expression levels of DLAT, DLD, FDX1, MTF1 was significantly downregulated in tumor samples. This evidence concerns the gene CDKN2A and neoplasm.